9408 Sun et al.
Asian J. Chem.
obtain new DOPA analogue by starting from nature amino
acid. We employed L-tyrosine as starting material via synthetic
strategy based on Baeyer-Villiger oxidation, methylation under
Coggins's condition8 and finally chlorination by Cl2 gas in
dichloromethane to give new DOPA analogue 16 (Fig. 3).
Preparation of L-N-methyl-3-hydroxy-4-methoxy-6-
chlorophenylalanine methyl ester 16: To a stirred solution of
compound 15 (0.24 g, 1 mmol) in dichloromethane was
bubbled chlorine at 0 ºC until 15 was converted completed
showed by TLC plate. The yellow reaction solution was
concentrated at 0 ºC to give slight yellow oil, which was
chromato-graphed to yield final product 16 as pale yellow oil,
107 mg, yield 39.1 %. 1H NMR (CDCl3, 400 Hz) δ ppm: 6.82
(s, 1H, Ar-H), 6.79(s, 1H, Ar-H), 3.85(s, 3H, COOMe), 3.68
(s, 3H, OMe), 3.63-3.48 (m, 1H, CH), 3.05-2.93 (m, 2H, CH2),
2.39 (s, 3H, NMe).
OH
OH
OH
COCH3
COCH3
CH3COCl/AlCl3
80.1%
SOCl2/MeOH
100%
CbzCl/Na2CO3
Et2O/H2O
88.8%
COOCH3
COOH
COOH
NH2. HCl
NH2
NH2
3
9
10
OCH3
COCH3
OCH3
OH
OCOCH3
REFERENCES
COCH3
Sat.NaHCO3
MeOH/H2O
MeI/NaH
m-CPBA
CH2Cl2
85.4%
(two steps)
THF/DMF
62%
1. (a) S. Omura and H. Tomoda, Pure Appl. Chem., 66, 2267 (1994); (b)
S. Omura, D.V. der Pyl, J. Inokoshi, Y. Takahashi and H. Takeshima, J.
Antibiot. (Tokyo), 46, 222 (1993); (c) K. Shiomi, H. Yang, J. Inokoshi,
D. Van der Pyl, A. Nakagawa, H. Takeshima and S. Omura, J. Antibiot.
(Tokyo), 46, 229 (1993).
COOCH3
NCbz
COOCH3
COOCH3
Me
MeNCbz
13
NHCbz
11
12
OCH3
OH
OCH3
OH
OCH3
OH
gas
2. L. Ciasullo, A. Casapullo, A. Cutignano, G. Bifulco, C. Debitus, J.
Hooper, L. Gomez-Paloma and R. Riccio, J. Nat. Prod., 65, 407 (2002).
3. (a) J.F. Siuda, J. Org. Chem., 40, 3611 (1975); (b) M. Kawai, M. Chorew,
J.M. Rose and M. Goodman, J. Med. Chem., 23, 420 (1980).
4. M.E. Jung and T.I. Lazarova, J. Org. Chem., 62, 1553 (1997).
5. D.L. Boger and D. Yohannes, J. Org. Chem., 52, 5283 (1987).
6. C. Chen Y.F. Zhu and K. Wilcoxen, J. Org. Chem., 65, 2574 (2000).
7. D.Q. Sun, Turk. J. Chem., 34, 181 (2010).
H2, Pd/C
Cl2
CH3OH
100%
CH2Cl2
Cl
COOCH3
COOCH3
COOCH3
NHMe
15
NHMe
16
MeNCbz
14
Fig. 3
8. J.R. Coggins and N.L. Benoiton, Can. J. Chem., 49, 1968 (1971).
9. (a) Y.L. Song, M.L. Peach, P.P. Roller, S. Qiu, S.M. Wang and Y.Q.
Long, J. Med. Chem., 49, 1585 (2006); (b) M.R. Heinrich and W.
Steglich, Tetrahedron, 59, 9231 (2003).
Melting points were determined with an electrothermal
digital melting point apparatus and were uncorrected. Optical
rotation were recorded on a Perkin-Elmer Model 341 polari-
meter, at the sodium D line. NMR and spectra were run either
on Bruker-200 and Bruker-300 or on Varian-400.
10. S. Kobayashi, H. Tanaka, H. Amii and K. Uneyama, Tetrahedron, 59,
1547 (2003).
11. R.J. Chen, D.G. Zhu, Z.Q. Hu, Z.M. Zheng and X.C. Chen, Tetrahedron:
Asymm., 21, 39 (2010).
Compound 99, 109, 119a, 125, 1310, 147, 1511 were prepared
based on the procedures reported in literatures.